Skip to main content

Table 1  Patinent profile and operation

From: Optimal patient selection for maze procedure in patients undergoing mitral valve disease

 

(n = 43)

Age

70.7 ± 8.2

Sex (Female)

18 (41.9%)

Body height (cm)

162.0 ± 9.9

Body weight (kg)

58.1 ± 12.1

AF period (months)

47.4 ± 66.5 (2〜360)

AF period ≥ 3 years

18 (42.9%)

F-wave height (mV)

0.19 ± 0.09

F-wave ≥ 0.1 mV

36 (83.7%)

LAD (mm)

51.2 ± 8.2

LAD ≥ 55 mm

13 (30.2%)

EF (%)

54.2 ± 10.5

TRPG (mmHg)

33.0 ± 13.1

BNP (pg/ml)

297.0 ± 262.9

Preoperative oral beta blocker

30 (69.8%)

Preoperative oral antiarrhythmic drugs

11 (25.6%)

Operation time (min)

287.5 ± 44.7

Cardiopulmonary bypass time (min)

161.0 ± 29.4

Aortic cross clamp time (min)

114.4 ± 22.9

Isolated mitral valve surgery

4 (9.3%)

Combined valve surgery

39 (90.7%)

Simultaneous coronary artery bypass grafting

1 (2.3%)

Aortic valve surgery

0

  1. AF atrial fibrillation, LAD left atrial diameter, EF ejection fraction, TRPG tricuspid regurgitation peak gradient, BNP brain natriuretic peptide